Literature DB >> 501196

Factor VIII-related antigen in human blood platelets: localization and release by thrombin and collagen.

M B Zucker, M J Broekman, K L Kaplan.   

Abstract

Human platelets contain 0.61 +/- 0.06 (S.E.) U of VIIIR:Ag per 10(9) platelets or about 25% of the circulating antigen in whole blood. Assay of subcellular fractions obtained by sucrose density-gradient centrifugation of disrupted platelets indicates that over 85% of the VIIIR:Ag is in the alpha granule fraction with other nonenzymatic proteins which can be released by treating platelets with collagen or thrombin. Seven percent or less is in the membrane fraction. After exposure of platelet suspensions to an optimal concentration of collagen, the supernatants contain, at most, 30% of the total amount of VIIIR:Ag in the platelets but a higher percentage of other releasable substances. After exposure to thrombin, the supernatants contain virtually no VIIIR:Ag. These low values are attributed to release of a limited amount of VIIIR:Ag by collagen or thrombin rather than to adsorption or destruction of antigen, for several reasons. (1) VIIIR:Ag can be recovered in the platelet residue as effectively as in control samples. (2) The antigen cannot be detected on the surface of collagen- or thrombin-stimulated platelets. (3) Relatively little released antigen is adsorbed by collagen or destroyed by thrombin. Release of VIIR:Ag by collagen is markedly reduced by aspirin, and release of the antigen as well as fibrinogen from platelets is much slower than release of 14C-serotonin and beta-TG.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 501196

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  21 in total

1.  Immunoelectron-microscopic studies of human platelet thrombospondin, von Willebrand factor, and fibrinogen redistribution during clot formation.

Authors:  S C Watkins; V Raso; H S Slayter
Journal:  Histochem J       Date:  1990-09

2.  Transplantation of normal bone marrow into a pig with severe von Willebrand's disease.

Authors:  E J Bowie; L A Solberg; D N Fass; C M Johnson; G J Knutson; M L Stewart; L J Zoecklein
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

3.  von Willebrand protein facilitates platelet incorporation in polymerizing fibrin.

Authors:  J Loscalzo; A Inbal; R I Handin
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

Review 4.  Laboratory investigation of platelet function: a review of methodology.

Authors:  D A Yardumian; I J Mackie; S J Machin
Journal:  J Clin Pathol       Date:  1986-07       Impact factor: 3.411

5.  Optimal techniques for the immunocytochemical demonstration of beta-thromboglobulin, platelet factor 4, and fibrinogen in the alpha granules of unstimulated platelets.

Authors:  P E Stenberg; M A Shuman; S P Levine; D F Bainton
Journal:  Histochem J       Date:  1984-09

6.  Isolation and partial characterization of platelet alpha-granule membranes.

Authors:  J Van der Meulen; W Furuya; S Grinstein
Journal:  J Membr Biol       Date:  1983       Impact factor: 1.843

7.  Reevaluation of the role of the polar groups of collagen in the platelet-collagen interaction.

Authors:  C M Chesney; D D Pifer; L J Crofford; K M Huch
Journal:  Am J Pathol       Date:  1983-08       Impact factor: 4.307

8.  Von Willebrand protein binds to extracellular matrices independently of collagen.

Authors:  D D Wagner; M Urban-Pickering; V J Marder
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

9.  Immunofluorescent localization of adhesive glycoproteins in resting and thrombin-stimulated platelets.

Authors:  J D Wencel-Drake; E F Plow; T S Zimmerman; R G Painter; M H Ginsberg
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

10.  Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released.

Authors:  Joseph E Italiano; Jennifer L Richardson; Sunita Patel-Hett; Elisabeth Battinelli; Alexander Zaslavsky; Sarah Short; Sandra Ryeom; Judah Folkman; Giannoula L Klement
Journal:  Blood       Date:  2007-10-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.